WITHDRAWN: Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression
Authors:
- Indriwanto Sakidjan AtmosudigdoIAIndriwanto Sakidjan Atmosudigdo
- Raymond PranataRPRaymond Pranata
- Michael Anthonius LimMLMichael Anthonius Lim
- Joshua HenrinaJHJoshua Henrina
- Emir YonasEYEmir Yonas
- Rachel VaniaRVRachel Vania
- Basuni RadiBRBasuni Radi
- 1 February 2021
- journal article
- retraction
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, ChinaAllergy, 2020
- Low Serum Cholesterol Level Among Patients with COVID-19 Infection in Wenzhou, ChinaSSRN Electronic Journal, 2020
- Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP)BMC Public Health, 2019
- Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of AtherosclerosisClinical Chemistry, 2016
- Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosisLipids in Health and Disease, 2012
- OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signalingAtherosclerosis, 2011
- Dyslipidemia Prevalence, Treatment, and Control in the Multi-Ethnic Study of Atherosclerosis (MESA)Circulation, 2006
- Antiinflammatory Properties of HDLCirculation Research, 2004
- Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the hostJournal of Lipid Research, 2004
- High-Density Lipoprotein Loses Its Anti-Inflammatory Properties During Acute Influenza A InfectionCirculation, 2001